Literature DB >> 35928342

Overt Disseminated Intravascular Coagulation with Severe Hypofibrinogenemia During Veno-Venous Extracorporeal Membrane Oxygenation.

Stephen Yang1, Brittney Williams1, David Kaczorowski2, Michael Mazzeffi1.   

Abstract

Disseminated intravascular coagulation (DIC) is a life-threatening hematologic derangement characterized by dysregulated thrombin generation and excessive fibrinolysis. However, DIC is poorly characterized in the extracorporeal membrane oxygenation (ECMO) population, and the underlying mechanisms are not well understood. Several mechanisms contribute to DIC in ECMO, including consumption of coagulation factors, acquired von Willebrand's syndrome leading to thrombocytopenia, and hyperfibrinolysis. There are few case reports of DIC in adult ECMO patients. Most are in the context of venoarterial ECMO, which is typically used in the setting of cardiogenic shock and cardiac arrest. These disease states themselves are known to be associated with DIC, liver failure, impaired anticoagulant mechanisms, and increased fibrinolysis. We present an unusual case of a 74-year-old man who developed overt DIC during veno-venous (VV) ECMO. DIC resulted in clinical bleeding and severe hypofibrinogenemia requiring massive cryoprecipitate transfusion of 87 pooled units. When the patient was decannulated from ECMO, his platelet count and fibrinogen concentration improved within 24 hours, suggesting that ECMO was a proximate cause of his DIC. © Copyright 2022 AMSECT.

Entities:  

Keywords:  DIC; ECMO; coagulation; coagulopathy.

Mesh:

Substances:

Year:  2022        PMID: 35928342      PMCID: PMC9302396          DOI: 10.1182/ject-148-152

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  14 in total

1.  Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients.

Authors:  Richard Cheng; Rory Hachamovitch; Michelle Kittleson; Jignesh Patel; Francisco Arabia; Jaime Moriguchi; Fardad Esmailian; Babak Azarbal
Journal:  Ann Thorac Surg       Date:  2013-11-08       Impact factor: 4.330

2.  [Acute ischemic gastric mucosal and duodenal lesions in dogs: "stress ulcer" after experimental disseminated intravascular coagulation].

Authors:  M M Linder; W Hartel; J Lenz
Journal:  Helv Chir Acta       Date:  1978-05

Review 3.  Disseminated Intravascular Coagulation.

Authors:  Benjamin M Boral; Dennis J Williams; Leonard I Boral
Journal:  Am J Clin Pathol       Date:  2016-12-24       Impact factor: 2.493

4.  Prospective observational study of hemostatic alterations during adult extracorporeal membrane oxygenation (ECMO) using point-of-care thromboelastometry and platelet aggregometry.

Authors:  Priya Nair; Dominik Johannes Hoechter; Hergen Buscher; Karthik Venkatesh; Susan Whittam; Joanne Joseph; Paul Jansz
Journal:  J Cardiothorac Vasc Anesth       Date:  2015-02-02       Impact factor: 2.628

5.  Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.

Authors:  Michael A Mazzeffi; Kenichi Tanaka; Alia Roberts; Raymond Rector; Jay Menaker; Zachary Kon; Kristopher B Deatrick; David Kaczorowski; Bartley Griffith; Daniel Herr
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-03       Impact factor: 2.628

6.  Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study.

Authors:  Balwinder Singh; Andrew C Hanson; Rabe Alhurani; Shihan Wang; Vitaly Herasevich; Rodrigo Cartin-Ceba; Daryl J Kor; Naseema Gangat; Guangxi Li
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

7.  Von Willebrand Factor-GP1bα Interactions in Venoarterial Extracorporeal Membrane Oxygenation Patients.

Authors:  Michael Mazzeffi; Shaheer Hasan; Ezeldeen Abuelkasem; Michael Meyer; Kristopher Deatrick; Bradley Taylor; Zachary Kon; Daniel Herr; Kenichi Tanaka
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-11-22       Impact factor: 2.628

Review 8.  Current Understanding of How Extracorporeal Membrane Oxygenators Activate Haemostasis and Other Blood Components.

Authors:  Andrew J Doyle; Beverley J Hunt
Journal:  Front Med (Lausanne)       Date:  2018-12-12

9.  Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.

Authors:  Bruce Cartwright; Hannah M Bruce; Geoffrey Kershaw; Nancy Cai; Jad Othman; David Gattas; Jacqueline L Robson; Sarah Hayes; Hayden Alicajic; Anna Hines; Alice Whyte; Nophanan Chaikittisilpa; Timothy James Southwood; Paul Forrest; Richard J Totaro; Paul G Bannon; Scott Dunkley; Vivien M Chen; Mark Dennis
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

10.  Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation.

Authors:  Hakeem Yusuff; Vasileios Zochios; Daniel Brodie
Journal:  ASAIO J       Date:  2020-08       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.